Literature DB >> 19660845

Management of patients at risk of osteoradionecrosis: results of survey of dentists and oral & maxillofacial surgery units in the United Kingdom, and suggestions for best practice.

Niall M H McLeod1, Michael C Bater, Peter A Brennan.   

Abstract

We aimed to find out whether dental practitioners take specific measures to identify patients who are at risk of osteoradionecrosis (ORN) of the jawbones; how oral and maxillofacial surgery units in the United Kingdom manage patients who have had radiotherapy and require dental extractions, and the evidence behind current practice. We sent postal questionnaires to 60 dentists and 117 maxillofacial units. Dentists were questioned about measures used to identify radiotherapy patients, and use of antibiotic prophylaxis. Maxillofacial units were questioned about the existence of written protocols and the measures used to minimise the risk of ORN. Thirty-five percent of dentists questioned ask specifically about head and neck cancer or radiotherapy as part of their medical history, and 5% of maxillofacial units questioned had written protocols for the management of patients who had had radiotherapy or had previously been diagnosed with ORN. Prophylactic antibiotics are recommended for patients at risk of ORN by 16% of dentists and 81% of maxillofacial units. Preoperative mouthwash is recommended by 59% of maxillofacial units. Identification of patients at risk of ORN is the first step in prevention but it is not done efficiently at present. Recommendations include the use of preoperative mouthwash and prophylactic antibiotics. Operations should be atraumatic and should be done by experienced clinicians. Copyright 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660845     DOI: 10.1016/j.bjoms.2009.06.128

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  4 in total

1.  Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts).

Authors:  Mir Sadat-Ali; Naif A AlMasoud; Tarek M Hegazi; Sadananda Acharya; Ahmed A Alsulaiman; Ayesha Ahmed; Methal I AlBayat
Journal:  Saudi Dent J       Date:  2021-12-23

2.  Antibiotic therapy for the prevention of osteoradionecrosis following tooth extraction in head-and-neck cancer patients postradiotherapy: An 11-year retrospective study.

Authors:  Luiz Felipe Palma; Marcelo Marcucci; Cíntia Maria Remondes; Leandro Chambrone
Journal:  Natl J Maxillofac Surg       Date:  2021-12-13

3.  Osteonecrosis of the Jaws in Dogs in Previously Irradiated Fields: 13 Cases (1989-2014).

Authors:  Ana Nemec; Boaz Arzi; Katherine Hansen; Brian G Murphy; Milinda J Lommer; Santiago Peralta; Frank J M Verstraete
Journal:  Front Vet Sci       Date:  2015-04-01

4.  Osteonecrosis of the jaws: a review and update in etiology and treatment.

Authors:  Guilherme H Ribeiro; Emanuely S Chrun; Kamile L Dutra; Filipe I Daniel; Liliane J Grando
Journal:  Braz J Otorhinolaryngol       Date:  2017-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.